Central Nervous System
FDA greenlights Neuralink for human trials
The US Food and Drug Administration (FDA) has approved Neuralink for its first in-human study. In a Twitter announcement, the…
Study commences for concussion saliva test for sportswomen
Marker Diagnostics will begin a study evaluating a saliva-based concussion test in women’s rugby players. The test, which is CE-certified…
Sun rises on Lithuania’s life sciences industry
Lithuania possesses one of the oldest languages still in use today, a tree which is amongst the most ancient in…
NICE recommends new digital therapies for patients with depression and anxiety
The UK's National Institute of Health and Care Excellence (NICE) has greenlit nine new digital therapies for patients with mental…
Are anti-nausea wearables effective?
Nausea is one of the most common symptoms people experience. It can arise from a disease, as a side effect…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Quest Diagnostics unveils new AI-based test service in US
Quest Diagnostics has announced the availability of a new risk assessment and care plan service across the US, called RestoreU…
FDA fast tracks speech software for ALS treatment
The U.S. Food and Drug Administration (FDA) has granted software developed by Aural Analytics as a breakthrough device. The designation…
NeuroRPM receives clearance from FDA for Parkinson’s monitoring app
Digital health company NeuroRPM has received clearance from the US Food and Drug Administration (FDA) for its artificial intelligence (AI)-powered…
Rowan-Virtua SOM and Durin report Alzheimer’s blood test data
Researchers from Rowan-Virtua School of Osteopathic Medicine (Rowan-Virtua SOM) and Durin Technologies have reported data from a blood test for…
Simon Fraser University to develop new biosensor for detecting Alzheimer’s
Scientists at the Simon Fraser University (SFU) Nanodevice Fabrication Group in Canada are developing a new biosensor that can detect…